DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE EXTENDING MONOPOLIES, KEEPING PRICES HIGH ON GLP-1S
Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind… Read More

Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind… Read More
Big Pharma Giant Johnson & Johnson Reports Earnings That Beating Wall… Read More
Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s… Read More
Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute… Read More
U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious… Read More
Big Pharma’s Innovation Rhetoric Designed to Keep Drug Prices High Rather… Read More
Brand Name Manufacturers’ Prices for Blockbuster GLP-1 Medications Are… Read More
Brand Name Drug Company Known for Egregious Product-Hopping Strategy Beats… Read More
Eli Lilly Signals Plan to Maintain Unsustainably High Prices on Blockbuster… Read More
Pharmaceutical Giants Continue to Outperform Wall Street Projections While… Read More
Major Pharmaceutical Companies Continue Growing Revenues While Sticking With… Read More
Big Pharma Giants Report Higher-Than-Expected Q4 Earnings Amid Continued Price… Read More